• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格尔德霉素选择性地针对 ERBB3 的新生形式进行靶向降解。

Geldanamycin selectively targets the nascent form of ERBB3 for degradation.

机构信息

Department of Biological Chemistry, University of California Los Angeles, Los Angeles, CA, USA.

出版信息

Cell Stress Chaperones. 2010 Sep;15(5):529-44. doi: 10.1007/s12192-009-0166-1. Epub 2010 Jan 19.

DOI:10.1007/s12192-009-0166-1
PMID:20084478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3006625/
Abstract

Heat shock protein 90 (HSP90) targets a broad spectrum of client proteins with divergent modes of interaction and consequences. The homologous epidermal growth factor receptor (EGFR) and ERBB2 receptors as well as kinase-deficient mutants thereof differ in their requirement for HSP90 in the nascent versus mature state of the receptor. Specific features of the kinase domain have been implicated for the selective association of HSP90 with mature ERBB2. We evaluated the role of HSP90 for the homologous ERBB3 receptor. ERBB3 is naturally kinase deficient, a central mediator in cell survival and stress response and the primary dimerization partner for ERBB2 in signaling. Cellular studies indicate that, similar to EGFR, the geldanamycin (GA) sensitivity of ERBB3 and HSP90 binding resides in the nascent state and is dependent on the presence of the kinase domain of ERBB3. Furthermore, despite its intrinsic lack of kinase activity and in contrast to the reported GA sensitivity of mature and kinase-deficient EGFR, the GA sensitivity of the nascent state of ERBB3 appears to be exclusive. Geldanamycin disrupts the interaction of ERBB3 and HSP90 and inhibits ERBB3 maturation at an early stage of synthesis, prior to export from the ER. Studies with a photo-convertible fusion protein of ERBB3 suggest geldanamycin sensitivity at a later stage in maturation, possibly through the putative role of HSP90 in structural proofreading.

摘要

热休克蛋白 90(HSP90)以不同的相互作用模式和结果靶向广泛的客户蛋白。同源表皮生长因子受体(EGFR)和 ERBB2 受体及其激酶缺陷突变体在受体的初始状态和成熟状态下对 HSP90 的需求不同。激酶结构域的特定特征被认为是 HSP90 与成熟 ERBB2 选择性结合的原因。我们评估了 HSP90 对同源 ERBB3 受体的作用。ERBB3 天然缺乏激酶活性,是细胞存活和应激反应的中心介质,也是 ERBB2 信号转导中的主要二聚化伴侣。细胞研究表明,与 EGFR 相似,GA 对 ERBB3 和 HSP90 结合的敏感性存在于初始状态,并且依赖于 ERBB3 激酶结构域的存在。此外,尽管 ERBB3 具有内在的缺乏激酶活性,并且与报道的成熟和激酶缺陷型 EGFR 的 GA 敏感性相反,ERBB3 的新生状态的 GA 敏感性似乎是排他性的。GA 破坏 ERBB3 和 HSP90 的相互作用,并在 ER 内从内质网输出之前,在合成的早期阶段抑制 ERBB3 的成熟。使用 ERBB3 的光转化融合蛋白的研究表明,在成熟的后期阶段存在 GA 敏感性,可能是通过 HSP90 在结构校对中的假定作用。

相似文献

1
Geldanamycin selectively targets the nascent form of ERBB3 for degradation.格尔德霉素选择性地针对 ERBB3 的新生形式进行靶向降解。
Cell Stress Chaperones. 2010 Sep;15(5):529-44. doi: 10.1007/s12192-009-0166-1. Epub 2010 Jan 19.
2
Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90.成熟的Erbb2对格尔德霉素的敏感性由其激酶结构域赋予,并由伴侣蛋白Hsp90介导。
J Biol Chem. 2001 Feb 2;276(5):3702-8. doi: 10.1074/jbc.M006864200. Epub 2000 Nov 8.
3
Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.表皮生长因子受体或ErbB3的表达促进格尔德霉素诱导的ErbB2下调。
Mol Cancer Res. 2009 Feb;7(2):275-84. doi: 10.1158/1541-7786.MCR-07-2183. Epub 2009 Feb 10.
4
Hsp90, not Grp94, regulates the intracellular trafficking and stability of nascent ErbB2.热休克蛋白90(Hsp90)而非葡萄糖调节蛋白94(Grp94)调控着新生表皮生长因子受体2(ErbB2)的细胞内运输和稳定性。
Cell Stress Chaperones. 2002 Jan;7(1):91-6. doi: 10.1379/1466-1268(2002)007<0091:hngrti>2.0.co;2.
5
Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex.表面电荷和疏水性决定了ErbB2与热休克蛋白90(Hsp90)伴侣复合物的结合。
Nat Struct Mol Biol. 2005 Feb;12(2):120-6. doi: 10.1038/nsmb885. Epub 2005 Jan 9.
6
Destabilization of the epidermal growth factor receptor (EGFR) by a peptide that inhibits EGFR binding to heat shock protein 90 and receptor dimerization.通过抑制表皮生长因子受体 (EGFR) 与热休克蛋白 90 和受体二聚体结合的肽来使 EGFR 失稳。
J Biol Chem. 2013 Sep 13;288(37):26879-86. doi: 10.1074/jbc.M113.492280. Epub 2013 Jul 29.
7
Flotillin depletion affects ErbB protein levels in different human breast cancer cells.小窝蛋白缺失影响不同人乳腺癌细胞中表皮生长因子受体(ErbB)蛋白水平。
Biochim Biophys Acta. 2014 Sep;1843(9):1987-96. doi: 10.1016/j.bbamcr.2014.04.013. Epub 2014 Apr 18.
8
Identification of an HSP90 modulated multi-step process for ERBB2 degradation in breast cancer cells.乳腺癌细胞中HSP90调控的ERBB2降解多步骤过程的鉴定
Oncotarget. 2016 Dec 20;7(51):85411-85429. doi: 10.18632/oncotarget.13392.
9
Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumors.野生型 EGFR 在癌细胞和肿瘤中通过与 HSP90 的直接相互作用而稳定。
Neoplasia. 2012 Aug;14(8):670-7. doi: 10.1593/neo.12986.
10
Anti-tumor activity of WK88-1, a novel geldanamycin derivative, in gefitinib-resistant non-small cell lung cancers with Met amplification.新型格尔德霉素衍生物 WK88-1 对伴 MET 扩增的吉非替尼耐药非小细胞肺癌的抗肿瘤活性。
Cancer Sci. 2014 Oct;105(10):1245-53. doi: 10.1111/cas.12497. Epub 2014 Sep 25.

引用本文的文献

1
ATP-Driven Nonequilibrium Activation of Kinase Clients by the Molecular Chaperone Hsp90.ATP 驱动的分子伴侣 HSP90 对激酶客户的非平衡激活。
Biophys J. 2020 Oct 20;119(8):1538-1549. doi: 10.1016/j.bpj.2020.08.038. Epub 2020 Sep 11.
2
analysis of putative cancer stem cell populations and chemosensitivity in the SW480 and SW620 colon cancer metastasis model.SW480和SW620结肠癌转移模型中假定癌症干细胞群体及化学敏感性分析
Oncol Lett. 2018 Jun;15(6):8516-8526. doi: 10.3892/ol.2018.8431. Epub 2018 Apr 4.
3
Combined BRAF and HSP90 Inhibition in Patients with Unresectable -Mutant Melanoma.联合 BRAF 和 HSP90 抑制治疗不可切除的 -突变型黑色素瘤患者。
Clin Cancer Res. 2018 Nov 15;24(22):5516-5524. doi: 10.1158/1078-0432.CCR-18-0565. Epub 2018 Apr 19.
4
Targeting HER2 by Combination Therapies.联合疗法靶向HER2
J Clin Oncol. 2018 Mar 10;36(8):808-811. doi: 10.1200/JCO.2017.77.1899. Epub 2018 Jan 30.
5
How Hsp90 and Cdc37 Lubricate Kinase Molecular Switches.热休克蛋白90(Hsp90)和细胞分裂周期蛋白37(Cdc37)如何调控激酶分子开关。
Trends Biochem Sci. 2017 Oct;42(10):799-811. doi: 10.1016/j.tibs.2017.07.002. Epub 2017 Aug 4.
6
HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death.HSP90 的活性对于 MLKL 的寡聚化和膜转位以及诱导细胞发生坏死性细胞死亡是必需的。
Cell Death Dis. 2016 Jan 14;7(1):e2051. doi: 10.1038/cddis.2015.386.
7
Targeting Hsp90 in urothelial carcinoma.针对尿路上皮癌中的热休克蛋白90
Oncotarget. 2015 Apr 20;6(11):8454-73. doi: 10.18632/oncotarget.3502.
8
Targeting HER3 by interfering with its Sec61-mediated cotranslational insertion into the endoplasmic reticulum.通过干扰HER3经Sec61介导的共翻译插入内质网来靶向HER3。
Oncogene. 2015 Oct 8;34(41):5288-94. doi: 10.1038/onc.2014.455. Epub 2015 Jan 26.
9
Phosphorylated and unphosphorylated serine 13 of CDC37 stabilize distinct interactions between its client and HSP90 binding domains.CDC37的丝氨酸13位点的磷酸化和未磷酸化状态稳定了其客户蛋白与热休克蛋白90(HSP90)结合结构域之间不同的相互作用。
Biochemistry. 2015 Feb 24;54(7):1493-504. doi: 10.1021/bi501129g. Epub 2015 Feb 11.
10
Anti-tumor activity of WK88-1, a novel geldanamycin derivative, in gefitinib-resistant non-small cell lung cancers with Met amplification.新型格尔德霉素衍生物 WK88-1 对伴 MET 扩增的吉非替尼耐药非小细胞肺癌的抗肿瘤活性。
Cancer Sci. 2014 Oct;105(10):1245-53. doi: 10.1111/cas.12497. Epub 2014 Sep 25.

本文引用的文献

1
Higher-order association states of cellular ERBB3 probed with photo-cross-linkable aptamers.用光可交联适体探测细胞内ERBB3的高阶缔合状态。
Biochemistry. 2008 Nov 18;47(46):11992-2005. doi: 10.1021/bi8004208. Epub 2008 Oct 23.
2
Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37.热休克蛋白90(Hsp90)依赖的蛋白激酶激活受Cdc37伴侣靶向去磷酸化调节。
Mol Cell. 2008 Sep 26;31(6):886-95. doi: 10.1016/j.molcel.2008.07.021.
3
Targeting Hsp90 prevents escape of breast cancer cells from tyrosine kinase inhibition.靶向热休克蛋白90可防止乳腺癌细胞逃避酪氨酸激酶抑制作用。
Cell Cycle. 2008 Sep 15;7(18):2936-41. doi: 10.4161/cc.7.18.6701. Epub 2008 Sep 30.
4
Mechanism of activation and inhibition of the HER4/ErbB4 kinase.HER4/ErbB4激酶的激活与抑制机制。
Structure. 2008 Mar;16(3):460-7. doi: 10.1016/j.str.2007.12.016.
5
Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus.ErbB2的内吞下调是由其C末端的裂解所刺激的。
Mol Biol Cell. 2007 Sep;18(9):3656-66. doi: 10.1091/mbc.e07-01-0025. Epub 2007 Jul 11.
6
Method for real-time monitoring of protein degradation at the single cell level.单细胞水平蛋白质降解实时监测方法
Biotechniques. 2007 Apr;42(4):446, 448, 450. doi: 10.2144/000112453.
7
High HSP90 expression is associated with decreased survival in breast cancer.HSP90高表达与乳腺癌患者生存率降低相关。
Cancer Res. 2007 Apr 1;67(7):2932-7. doi: 10.1158/0008-5472.CAN-06-4511.
8
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3.激酶失活的HER3介导的HER家族酪氨酸激酶抑制剂治疗逃逸
Nature. 2007 Jan 25;445(7126):437-41. doi: 10.1038/nature05474. Epub 2007 Jan 7.
9
Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.热休克蛋白90辅助伴侣蛋白Aha1的下调可挽救囊性纤维化中囊性纤维化跨膜传导调节因子的错误折叠。
Cell. 2006 Nov 17;127(4):803-15. doi: 10.1016/j.cell.2006.09.043.
10
Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity.热休克蛋白90(Hsp90)结合的丧失会上调Src依赖的表皮生长因子受体2(ErbB2)活性。
Mol Cell Biol. 2007 Jan;27(1):220-8. doi: 10.1128/MCB.00899-06. Epub 2006 Oct 9.